Neri D - Search Results

1

Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties.

Elsayed A, Pellegrino C, Plüss L, Peissert F, Benz R, Ulrich F, Thorhallsdottir G, Plaza SD, Villa A, Mock J, Puca E, De Luca R, Manz MG, Halin C, Neri D. Elsayed A, et al. Among authors: neri d. MAbs. 2023 Jan-Dec;15(1):2220839. doi: 10.1080/19420862.2023.2220839. MAbs. 2023. PMID: 37288872 Free PMC article.

2

Infrared photodetection for the in vivo localisation of phage-derived antibodies directed against angiogenic markers.

Birchler M, Neri G, Tarli L, Halin C, Viti F, Neri D. Birchler M, et al. Among authors: neri d, neri g. J Immunol Methods. 1999 Dec 10;231(1-2):239-48. doi: 10.1016/s0022-1759(99)00160-x. J Immunol Methods. 1999. PMID: 10648941

3

Antibody-Based targeting of angiogenesis.

Halin C, Neri D. Halin C, et al. Among authors: neri d. Crit Rev Ther Drug Carrier Syst. 2001;18(3):299-339. Crit Rev Ther Drug Carrier Syst. 2001. PMID: 11442202 Review.

4

Antibody-based targeting of angiogenesis.

Halin C, Zardi L, Neri D. Halin C, et al. Among authors: neri d. News Physiol Sci. 2001 Aug;16:191-4. doi: 10.1152/physiologyonline.2001.16.4.191. News Physiol Sci. 2001. PMID: 11479371 Review.

5

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

Halin C, Rondini S, Nilsson F, Berndt A, Kosmehl H, Zardi L, Neri D. Halin C, et al. Among authors: neri d. Nat Biotechnol. 2002 Mar;20(3):264-9. doi: 10.1038/nbt0302-264. Nat Biotechnol. 2002. PMID: 11875427

6

Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides.

Niesner U, Halin C, Lozzi L, Günthert M, Neri P, Wunderli-Allenspach H, Zardi L, Neri D. Niesner U, et al. Among authors: neri p, neri d. Bioconjug Chem. 2002 Jul-Aug;13(4):729-36. doi: 10.1021/bc025517+. Bioconjug Chem. 2002. PMID: 12121127

7

Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins.

Halin C, Niesner U, Villani ME, Zardi L, Neri D. Halin C, et al. Among authors: neri d. Int J Cancer. 2002 Nov 10;102(2):109-16. doi: 10.1002/ijc.10674. Int J Cancer. 2002. PMID: 12385005

8

An antibody-calmodulin fusion protein reveals a functional dependence between macromolecular isoelectric point and tumor targeting performance.

Melkko S, Halin C, Borsi L, Zardi L, Neri D. Melkko S, et al. Among authors: neri d. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1485-90. doi: 10.1016/s0360-3016(02)03927-5. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459375

9

Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.

Halin C, Gafner V, Villani ME, Borsi L, Berndt A, Kosmehl H, Zardi L, Neri D. Halin C, et al. Among authors: neri d. Cancer Res. 2003 Jun 15;63(12):3202-10. Cancer Res. 2003. PMID: 12810649

10

Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin.

Matter CM, Schuler PK, Alessi P, Meier P, Ricci R, Zhang D, Halin C, Castellani P, Zardi L, Hofer CK, Montani M, Neri D, Lüscher TF. Matter CM, et al. Among authors: neri d. Circ Res. 2004 Dec 10;95(12):1225-33. doi: 10.1161/01.RES.0000150373.15149.ff. Epub 2004 Nov 11. Circ Res. 2004. PMID: 15539632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters